Orforglipron Oral Tablet Delivers Up to 11 Percent Weight Loss in Obese Adults —No Injections Required: 72-Week Trial

Canada: A large international clinical trial has demonstrated that the oral GLP-1 receptor agonist orforglipron can produce substantial and sustained weight loss in adults with obesity who do not have…

Continue ReadingOrforglipron Oral Tablet Delivers Up to 11 Percent Weight Loss in Obese Adults —No Injections Required: 72-Week Trial

Cardiovascular Risk Highest in Mothers with Hypertension, Diabetes, or Both: Study

A new study has determined that mothers who experienced pre-pregnancy hypertension, hypertensive disorders of pregnancy (HDP), diabetes, or any combination of these three diseases are at greatly elevated risks of…

Continue ReadingCardiovascular Risk Highest in Mothers with Hypertension, Diabetes, or Both: Study

EASD Issues First-Ever Global Clinical Practice Guideline on Diabetes Distress

Guideline development and inclusiveness The guideline was developed in line with internationally recognised standards, including the GRADE methodology and the RIGHT reporting statement, and reflects the EASD’s newly established Standard…

Continue ReadingEASD Issues First-Ever Global Clinical Practice Guideline on Diabetes Distress

Rising Burden of Asthma and COPD Among Older Indians Linked to Social and Household Factors, Finds Study

India: A new study published in the Archives of Public Health sheds light on the growing burden of chronic lung diseases—Asthma and Chronic Obstructive Pulmonary Disease (COPD)—among India’s middle-aged and…

Continue ReadingRising Burden of Asthma and COPD Among Older Indians Linked to Social and Household Factors, Finds Study

Hypoglycaemia Awareness Key to Predicting Severe Events in Type 1 Diabetes, Study Shows

UK: People with type 1 diabetes who experience impaired awareness of hypoglycaemia (IAH) face a markedly higher risk of severe low-blood-sugar episodes when their glucose levels drop frequently, according to…

Continue ReadingHypoglycaemia Awareness Key to Predicting Severe Events in Type 1 Diabetes, Study Shows